A clinical-stage biotechnology company focused on developing small-molecule therapeutics for the treatment of various cancers, including targeting KRAS mutations, HER2+ breast cancer, and other malignancies.
South San Francisco, CA, United States~92 employeesFounded Jan 2016Website